Comprehension For OTC Naloxone (CONFER) Pivotal Label Comprehension Study – Task 3 Study Report

This report was released on January 17, 2019, by the U.S. Food and Drug Administration (FDA). It reports the FDA's efforts to facilitate labeling for an over-the-counter (OTC) version of naloxone. The FDA developed a draft model drug facts label (DFL) and an accompanying simple pictogram that could be placed next to the DFL to correspond with the DFL directions. This report presents the findings of the label comprehension study . . .